Short Interest in Avinger, Inc. (NASDAQ:AVGR) Drops By 65.2%

Avinger, Inc. (NASDAQ:AVGRGet Free Report) saw a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 2,300 shares, a decline of 65.2% from the January 15th total of 6,600 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average daily volume of 17,200 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on AVGR shares. StockNews.com initiated coverage on shares of Avinger in a research report on Monday. They issued a “hold” rating for the company. HC Wainwright upped their price objective on shares of Avinger from $1.60 to $5.00 and gave the company a “buy” rating in a research note on Monday, November 13th.

Check Out Our Latest Stock Analysis on Avinger

Institutional Trading of Avinger

A number of institutional investors have recently added to or reduced their stakes in AVGR. Dimensional Fund Advisors LP bought a new position in shares of Avinger in the first quarter valued at approximately $64,000. Renaissance Technologies LLC bought a new position in shares of Avinger in the second quarter valued at approximately $42,000. Armistice Capital LLC raised its position in shares of Avinger by 7.8% in the fourth quarter. Armistice Capital LLC now owns 720,136 shares of the medical device company’s stock valued at $781,000 after purchasing an additional 52,000 shares during the period. Finally, Prosperity Wealth Management Inc. bought a new position in shares of Avinger in the second quarter valued at approximately $49,000. 8.14% of the stock is currently owned by institutional investors and hedge funds.

Avinger Price Performance

NASDAQ:AVGR traded up $0.18 during mid-day trading on Monday, reaching $2.98. The stock had a trading volume of 16,691 shares, compared to its average volume of 14,303. The stock has a market cap of $4.08 million, a P/E ratio of -0.09 and a beta of 1.33. The business’s 50 day moving average is $2.84 and its 200 day moving average is $5.38. Avinger has a fifty-two week low of $2.50 and a fifty-two week high of $20.70.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Featured Stories

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.